These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 15276067)
1. Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2'-2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000. Al-Madhoun AS; van der Wilt CL; Loves WJ; Padron JM; Eriksson S; Talianidis I; Peters GJ Biochem Pharmacol; 2004 Aug; 68(4):601-9. PubMed ID: 15276067 [TBL] [Abstract][Full Text] [Related]
2. Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780. Ruiz van Haperen VW; Veerman G; Eriksson S; Stegmann AP; Peters GJ Semin Oncol; 1995 Aug; 22(4 Suppl 11):35-41. PubMed ID: 7481843 [TBL] [Abstract][Full Text] [Related]
3. Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. Ruiz van Haperen VW; Veerman G; Eriksson S; Boven E; Stegmann AP; Hermsen M; Vermorken JB; Pinedo HM; Peters GJ Cancer Res; 1994 Aug; 54(15):4138-43. PubMed ID: 8033147 [TBL] [Abstract][Full Text] [Related]
4. Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs. Bergman AM; Giaccone G; van Moorsel CJ; Mauritz R; Noordhuis P; Pinedo HM; Peters GJ Eur J Cancer; 2000 Oct; 36(15):1974-83. PubMed ID: 11000580 [TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine. van Haperen VW; Veerman G; Vermorken JB; Pinedo HM; Peters G Biochem Pharmacol; 1996 Apr; 51(7):911-8. PubMed ID: 8651941 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. van Bree C; Castro Kreder N; Loves WJ; Franken NA; Peters GJ; Haveman J Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):237-44. PubMed ID: 12182997 [TBL] [Abstract][Full Text] [Related]
7. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase. Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Beauséjour CM; Gagnon J; Primeau M; Momparler RL Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells. Ohmine K; Kawaguchi K; Ohtsuki S; Motoi F; Egawa S; Unno M; Terasaki T Pharm Res; 2012 Jul; 29(7):2006-16. PubMed ID: 22419259 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK. Nakano T; Saiki Y; Kudo C; Hirayama A; Mizuguchi Y; Fujiwara S; Soga T; Sunamura M; Matsumura N; Motoi F; Unno M; Horii A Biochem Biophys Res Commun; 2015 Sep; 464(4):1084-1089. PubMed ID: 26196746 [TBL] [Abstract][Full Text] [Related]
11. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Kroep JR; Loves WJ; van der Wilt CL; Alvarez E; Talianidis I; Boven E; Braakhuis BJ; van Groeningen CJ; Pinedo HM; Peters GJ Mol Cancer Ther; 2002 Apr; 1(6):371-6. PubMed ID: 12477049 [TBL] [Abstract][Full Text] [Related]
13. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines. Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236 [TBL] [Abstract][Full Text] [Related]
15. DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. Saiki Y; Yoshino Y; Fujimura H; Manabe T; Kudo Y; Shimada M; Mano N; Nakano T; Lee Y; Shimizu S; Oba S; Fujiwara S; Shimizu H; Chen N; Nezhad ZK; Jin G; Fukushige S; Sunamura M; Ishida M; Motoi F; Egawa S; Unno M; Horii A Biochem Biophys Res Commun; 2012 Apr; 421(1):98-104. PubMed ID: 22490663 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity. Johnson AJ; Brown MN; Black ME Biochem Biophys Res Commun; 2011 Dec; 416(1-2):199-204. PubMed ID: 22093835 [TBL] [Abstract][Full Text] [Related]
18. Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. Hodzic J; Giovannetti E; Diosdado B; Adema AD; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1214-22. PubMed ID: 22132977 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line]. Dong M; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Zha YY; Lu HY; Wu M Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):323-8. PubMed ID: 15059518 [TBL] [Abstract][Full Text] [Related]
20. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. Grégoire V; Rosier JF; De Bast M; Bruniaux M; De Coster B; Octave-Prignot M; Scalliet P Radiother Oncol; 2002 Jun; 63(3):329-38. PubMed ID: 12142097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]